Merck And Co Inc Income Statement Quarterly
MRK
|
Select the Financial Report: |
Period: |
Fiscal Year: |
|
|
|
|
INCOME STATEMENT
(Quarterly GAAP In millions $) |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
| Total Revenue |
16,112.00 |
15,775.00 |
14,631.00 |
15,962.00 |
15,035.00 |
| Cost of Goods and Services Sold |
3,745.00 |
3,540.00 |
3,912.00 |
4,264.00 |
4,024.00 |
| Gross
Profit |
12,367.00 |
12,235.00 |
10,719.00 |
11,698.00 |
11,011.00 |
| Selling, Administration, Marketing |
2,739.00 |
2,483.00 |
2,804.00 |
2,519.00 |
2,702.00 |
| Depriciation & Amortization |
- |
- |
- |
- |
- |
| Research and Development Expense |
3,500.00 |
3,992.00 |
9,627.00 |
3,307.00 |
13,321.00 |
| Restructuring Charges |
80.00 |
123.00 |
255.00 |
126.00 |
151.00 |
| Other exp. /-income |
- |
- |
- |
- |
- |
| Special Items |
- |
- |
- |
- |
- |
| Total operating costs including COS |
10,064.00 |
10,138.00 |
16,598.00 |
10,216.00 |
20,198.00 |
| Operating income/-loss
|
6,048.00 |
5,637.00 |
-1,967.00 |
5,746.00 |
-5,163.00 |
|
Other Deductions / - Income |
| Interest expense |
- |
- |
- |
- |
- |
| Interest income |
- |
- |
- |
- |
- |
| Net interest expense/-income |
- |
- |
- |
- |
- |
| Loss (Income) from Equity Method Investments |
- |
- |
- |
- |
- |
| Equity in income of affiliates |
- |
- |
- |
- |
- |
| Sale of Assets |
- |
- |
- |
- |
- |
| Financing Loss/ -Income |
- |
- |
- |
- |
- |
| Other loss/ -income |
-10,064.00 |
-33.00 |
-16,598.00 |
-10,216.00 |
-20,198.00 |
| Costs Expenses And Other |
10,106.00 |
- |
16,677.00 |
10,342.00 |
20,370.00 |
| Total costs & expenses |
10,106.00 |
10,105.00 |
16,677.00 |
10,342.00 |
20,370.00 |
| Income /-loss before income taxes |
6,006.00 |
5,670.00 |
-2,046.00 |
5,620.00 |
-5,335.00 |
| Income taxes expenses/-benefit |
545.00 |
903.00 |
-820.00 |
870.00 |
637.00 |
| Income after income taxes |
5,461.00 |
4,767.00 |
-1,226.00 |
4,750.00 |
-5,972.00 |
| Net income/-loss
of other equity |
- |
- |
- |
- |
- |
| Income/-loss
from cont. Ops. |
5,461.00 |
4,767.00 |
-1,226.00 |
4,750.00 |
-5,972.00 |
| Accounting change |
- |
- |
- |
- |
- |
| Discontinued operations |
- |
- |
- |
- |
- |
| Extraordinary items |
- |
- |
- |
- |
- |
| Net Income/-loss |
5,461.00 |
4,767.00 |
-1,226.00 |
4,750.00 |
-5,972.00 |
| Noncontrolling interests |
6.00 |
5.00 |
-5.00 |
5.00 |
- |
| Prefered dividends |
- |
- |
- |
- |
- |
| Other |
- |
- |
5.00 |
- |
3.00 |
| Income/-loss to shareholder |
5,455.00 |
4,762.00 |
-1,226.00 |
4,745.00 |
-5,975.00 |
| EBIT |
6,006.00 |
5,670.00 |
-2,046.00 |
5,620.00 |
-5,335.00 |
| EBITD |
6,524.00 |
6,181.00 |
-1,544.00 |
6,072.00 |
-5,335.00 |
| EBITDA |
7,138.00 |
6,654.00 |
-1,082.00 |
6,634.00 |
-5,335.00 |
| Per
Share (GAAP Quarterly, in $) |
(Jun 30 2024)
II. Quarter |
(Mar 31 2024)
I. Quarter |
(Dec 31 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jun 30 2023)
II. Quarter |
| Basic EPS (excl. extra
items) |
2.15 |
1.88 |
-0.44 |
1.87 |
-2.35 |
| Extraordinary items |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic Net EPS |
2.15 |
1.88 |
-0.44 |
1.87 |
-2.35 |
| Basic shares outstanding (Mill.
of Units) |
2,537.21 |
2,532.98 |
2,807.14 |
2,537.43 |
2,542.55 |
| EPS other shares |
- |
- |
- |
- |
- |
| Diluted Net EPS |
2.14 |
1.87 |
-0.44 |
1.86 |
-2.35 |
| Diluted average shares (Mill.
of Units) |
2,549.07 |
2,546.52 |
2,807.14 |
2,551.08 |
2,542.55 |
| Dividend per share |
0.779 |
0.766 |
0.66 |
0.727 |
- |
|
|
